pindolol has been researched along with milnacipran in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, S; Horisawa, T; Kato, T; Kinomura, N; Kodo, T; Koyama, K; Masumoto, S; Matsumoto, K; Matsumoto, Y; Oki, H; Yabuuchi, K; Yoshinaga, H | 1 |
| Briley, M; Moret, C | 1 |
| Isaac, MB; Isaac, MT | 1 |
| Gallo, F; Isaac, MB; Isaac, MT; Tournoux, A | 1 |
| Morphy, R; Rankovic, Z | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for pindolol and milnacipran
| Article | Year |
|---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for pindolol and milnacipran
| Article | Year |
|---|---|
Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects.
Topics: Adrenergic Agents; Adrenocorticotropic Hormone; Adult; Age Factors; Cyclopropanes; Depressive Disorder; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Milnacipran; Pindolol; Prolactin; Psychiatric Status Rating Scales; Regression Analysis; Serotonin Agents; Time Factors; Treatment Outcome | 2003 |
Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Milnacipran; Pindolol; Psychiatric Status Rating Scales | 2003 |
2 other study(ies) available for pindolol and milnacipran
| Article | Year |
|---|---|
Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT
Topics: Animals; Antidepressive Agents; Cytochrome P-450 CYP2D6 Inhibitors; Dioxanes; Drug Partial Agonism; Humans; Male; Piperidines; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Plasma Membrane Transport Proteins | 2017 |
Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus.
Topics: Adrenergic beta-Antagonists; Animals; Cyclopropanes; Extracellular Space; Guinea Pigs; Hydroxyindoleacetic Acid; Hypothalamus; Kinetics; Male; Methoxyhydroxyphenylglycol; Milnacipran; Norepinephrine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1997 |